The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| BBLG | -66.3% | -99.97% | -66.06% | -100% |
| S&P | +14.77% | +87.2% | +13.35% | +237% |
Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.
No news articles found for Bone Biologics.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00K | 0.0% |
| Gross Profit | $0.00K | 0.0% |
| Market Cap | $5.01M | 12.2% |
| Market Cap / Employee | $2.50M | 0.0% |
| Employees | 2 | 0.0% |
| Net Income | -$666.74K | 29.1% |
| EBITDA | -$715.27K | 24.8% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $6.05M | 69.6% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00K | 0.0% |
| Short Term Debt | $0.00K | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -75.76% | 15.8% |
| Return On Invested Capital | -92.42% | -148.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$591.38K | -3.4% |
| Operating Free Cash Flow | -$591.38K | -3.4% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.80 | 0.90 | 0.75 | 0.71 | -39.47% |
| Price to Tangible Book Value | 3.12 | 4.07 | 0.75 | 0.71 | -87.67% |
| Enterprise Value to EBITDA | 0.35 | 0.19 | 5.87 | 1.46 | -922.07% |
| Return on Equity | -128.7% | -129.5% | -88.8% | -80.5% | -26.30% |
| Total Debt | $0.00K | $0.00K | $0.00K | $0.00K | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
